Pyroglutamic Acidosis – An Underrecognised Entity Associated with Acetaminophen Use

[1] Mehta AN, Emmett JB, Emmett M. GOLD MARK: an anion gap mnemonic for the 21st century. Lancet 2008;372(9642):892. doi:10.1016/S0140-6736(08)61398-7 Mehta AN Emmett JB Emmett M. GOLD MARK: an anion gap mnemonic for the 21st century . Lancet 2008 ; 372 ( 9642 ): 892 . DOI: 10.1016/S0140-6736(08)61398-7 Open DOISearch in Google Scholar

[2] Emmett M. Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): A tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. Clin J Am Soc Nephrol 2014;9(1):191–200. doi:10.2215/CJN.07730713 Emmett M. Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): A tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle . Clin J Am Soc Nephrol 2014 ; 9 ( 1 ): 191 – 200 . DOI: 10.2215/CJN.07730713 Open DOISearch in Google Scholar

[3] Creer MH, Lau BWC, Jones JD, Chan KM. Pyroglutamic acidemia in an adult patient. Clin Chem 1989;35(4):684–6. doi:10.1093/clinchem/35.4.684 Creer MH Lau BWC Jones JD Chan KM. Pyroglutamic acidemia in an adult patient . Clin Chem 1989 ; 35 ( 4 ): 684 – 6 . DOI: 10.1093/clinchem/35.4.684 Open DOISearch in Google Scholar

[4] Pitt JJ, Hauser S. Transient 5-oxoprolinuria and high anion gap metabolic acidosis: Clinical and biochemical findings in eleven subjects. Clin Chem 1998;44(7):1497–1503. doi:10.1093/clinchem/44.7.1497 Pitt JJ Hauser S. Transient 5-oxoprolinuria and high anion gap metabolic acidosis: Clinical and biochemical findings in eleven subjects . Clin Chem 1998 ; 44 ( 7 ): 1497 – 1503 . DOI: 10.1093/clinchem/44.7.1497 Open DOISearch in Google Scholar

[5] Liss DB, Paden MS, Schwarz ES, Mullins ME. What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure? Clin Toxicol 2013;51(9):817–27. doi:10.3109/15563650.2013.844822 Liss DB Paden MS Schwarz ES Mullins ME. What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure? Clin Toxicol 2013 ; 51 ( 9 ): 817 – 27 . DOI: 10.3109/15563650.2013.844822 Open DOISearch in Google Scholar

[6] Croal BL, Glen ACA, Kelly CJG, Logan RW. Transient 5-oxoprolinuria (pyroglutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy. Clin Chem 1998;44(2):336–340. doi:10.1093/clinchem/44.2.336 Croal BL Glen ACA Kelly CJG Logan RW. Transient 5-oxoprolinuria (pyroglutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy . Clin Chem 1998 ; 44 ( 2 ): 336 – 340 . DOI: 10.1093/clinchem/44.2.336 Open DOISearch in Google Scholar

[7] Bonham JR, Rattenbury JM, Meeks A, Pollitt RJ. Pyroglutamicaciduria from vigabatrin. Lancet 1989;1(8652):1452–3. doi:10.1016/S0140-6736(89)90158-X Bonham JR Rattenbury JM Meeks A Pollitt RJ. Pyroglutamicaciduria from vigabatrin . Lancet 1989 ; 1 ( 8652 ): 1452 – 3 . DOI: 10.1016/S0140-6736(89)90158-X Open DOISearch in Google Scholar

[8] Fenves AZ, Kirkpatrick HM, Patel VV, Sweetman L, Emmett M. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol 2006;1(3):441–7. doi:10.2215/CJN.01411005 Fenves AZ Kirkpatrick HM Patel VV Sweetman L Emmett M. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen . Clin J Am Soc Nephrol 2006 ; 1 ( 3 ): 441 – 7 . DOI: 10.2215/CJN.01411005 Open DOISearch in Google Scholar

[9] O’Brien LMN, Hooper M, Flemmer M, Marik PE. Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: An under diagnosed phenomenon. BMJ Case Rep [Internet] 2012:1–3. doi:10.1136/bcr.bcr.03.2012.6020 O’Brien LMN Hooper M Flemmer M Marik PE. Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: An under diagnosed phenomenon . BMJ Case Rep [Internet] 2012 : 1 – 3 . DOI: 10.1136/bcr.bcr.03.2012.6020 Open DOISearch in Google Scholar

[10] Tummers S, Oei SDX, Nooteboom F, Meenks SD, Wilting RM. Severe metabolic acidosis induced by 5-oxoproline accumulation after paracetamol and flucloxacillin administration. Neth J Crit Care 2020;28. Tummers S Oei SDX Nooteboom F Meenks SD Wilting RM. Severe metabolic acidosis induced by 5-oxoproline accumulation after paracetamol and flucloxacillin administration . Neth J Crit Care 2020 ; 28. Search in Google Scholar

[11] Wu SL, Wei TY, Lin SW, Su KY, Kuo CH. Metabolomics Investigation of voriconazole-induced hepatotoxicity in mice. Chem Res Toxicol 2019;32(9):1840–9. doi:10.1021/acs.chemrestox.9b00176 Wu SL Wei TY Lin SW Su KY Kuo CH. Metabolomics Investigation of voriconazole-induced hepatotoxicity in mice . Chem Res Toxicol 2019 ; 32 ( 9 ): 1840 – 9 . DOI: 10.1021/acs.chemrestox.9b00176 Open DOISearch in Google Scholar

[12] Hoshitsuki K, Molinelli AR, Inaba H, Rubnitz JE, Barker PJ. Metabolic Acidosis in a pediatric patient with leukemia and fungal infection. Clin Chem 2020;66(4):518–22. doi:10.1093/CLINCHEM/HVZ035 Hoshitsuki K Molinelli AR Inaba H Rubnitz JE Barker PJ. Metabolic Acidosis in a pediatric patient with leukemia and fungal infection . Clin Chem 2020 ; 66 ( 4 ): 518 – 22 . DOI: 10.1093/CLINCHEM/HVZ035 Open DOISearch in Google Scholar

[13] Mårtensson J, Gustafsson J, Larsson A. A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria). J Inherit Metab Dis 1989;12(2):120–30. doi:10.1007/BF01800713 Mårtensson J Gustafsson J Larsson A. A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria) . J Inherit Metab Dis 1989 ; 12 ( 2 ): 120 – 30 . DOI: 10.1007/BF01800713 Open DOISearch in Google Scholar